Transplantation of human undifferentiated embryonic stem cells into a myocardial infarction rat model

Stem Cells and Development

Volumn 16, Issue 1, 2007, Pages 25-29

  Xie, Chang Qing ^a,b   Zhang, Jifeng ^a,b   Xiao, Yan ^a   Zhang, Li ^a,c   Mou, Yongshan ^a,d   Liu, Xiaowei ^a   Akinbami, Mukaila ^a   Cui, Taixing ^a,b   Chen, Yuqing Eugene ^a,b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; HEART INFARCTION; HEART INJURY; HUMAN; HUMAN CELL; IN VIVO STUDY; LASER MICROSCOPE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TERATOMA; TRANSGENE; TREATMENT INDICATION;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GATA4 TRANSCRIPTION FACTOR; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; STEM CELL TRANSPLANTATION; TRANSCRIPTION FACTORS; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS; TROPONIN I;

RATTUS;

EID: 33847656206     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.110206     Document Type: Article

References (14)

1. Lee MS and RR Makkar. (2004). Stem-cell transplantation in myocardial infarction: a status report. Ann Intern Med 140:729-737.
2. Grogan M, MM Redfield, KR Bailey, GS Reeder, BJ Gersh, WD Edwards and RJ Rodeheffer. (1995). Long-term outcome of patients with biopsyproved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26:80-84.
3. Laflamme MA and CE Murry. (2005). Regenerating the heart. Nature Biotechnol 23:845-856.
4. Chien KR. (2006). Lost and found: cardiac stem cell therapy revisited. J Clin Invest 116:1838-1840.
5. Wollert KC and Drexler H. (2006). Cell-based therapy for heart failure. Curr Opin Cardiol. 21:234-239.
6. Kehat I, L Khimovich, O Caspi, A Gepstein, R Shofti, G Arbel, I Huber, J Satin, J Itskovitz-Eldor and L Gepstein. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature Biotechnol 22:1282-1289.
7. Xue T, HC Cho, FG Akar, SY Tsang, SP Jones, E Marban, GF Tomaselli and RA Li. (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111:11-20.
8. Drukker M, H Katchman, G Katz, S Even-Tov Friedman, E Shezen, E Horenstein, O Mandelboim, Y Reisner and N Benvenisty. (2006). Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 24:221-229.
9. Xiong C, DQ Tang, CQ Xie, L Zhang, KF Xu, WE Thompson, W Chou, LJ Chang, LJ Yang and YE Chen. (2005). Stable, High-efficiency Expression of Transgenes and Small Interfering RNAs in Human Embryonic Stem Cells Using Lentiviral Vectors. Stem Cells Dev 14:367-377.
10. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnol 19:971-974.
11. Hodgson DM, A Behfar, LV Zingman, GC Kane, C Perez-Terzic, AE Alekseev, M Puceat and A Terzic. (2004). Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287:H471-H479.
12. Haque R, SS Chaursaia, JH Wessel and PM Iuvone. (2002). Dual regulation of cryptochrome 1 mRNA expression in chicken retina by light and circadian oscillator. NeuroReport 13:2247-2251.
13. Behfar A, LV Zingman, DM Hodgson, JM Rauzier, GC Kane, A Terzic and M Puceat. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16:1558-1566.
14. Singla DK and B Sun. (2005). Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 332:135A-141A.